Literature DB >> 12069420

Fluorescence assay for the binding of ribonuclease A to the ribonuclease inhibitor protein.

Richele L Abel1, Marcia C Haigis, Chiwook Park, Ronald T Raines.   

Abstract

Ribonuclease A (RNase A) and the ribonuclease inhibitor protein (RI) form one of the tightest known protein-protein complexes. RNase A variants and homologues, such as G88R RNase A, that retain ribonucleolytic activity in the presence of RI are toxic to cancer cells. Herein, a new and facile assay is described for measuring the equilibrium dissociation constant (K(d)) and dissociation rate constant (k(d)) for complexes of RI and RNase A. This assay is based on the decrease in fluorescence intensity that occurs when a fluorescein-labeled RNase A binds to RI. To allow time for equilibration, the assay is most readily applied to those complexes with K(d) values in the nanomolar range or higher. Using this assay, the value of K(d) for the complex of RI with fluorescein-labeled G88R RNase A was determined to be 0.55 +/- 0.03 nM. In addition, the value of K(d) was determined for the complex of RI with unlabeled G88R RNase A to be 0.57 +/- 0.05 nM by using a competition assay with fluorescein-labeled G88R RNase A. Finally, the value of k(d) for the complex of RI with fluorescein-labeled G88R RNase A was determined to be (7.5 +/- 0.4) x 10(-3) s(-1) by monitoring the increase in fluorescence intensity upon dissociation. This assay can be used to characterize complexes of RI with a wide variety of RNase A variants and homologues, including those with cytotoxic activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069420     DOI: 10.1006/abio.2002.5678

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  17 in total

1.  Site-specific PEGylation endows a mammalian ribonuclease with antitumor activity.

Authors:  Thomas J Rutkoski; John A Kink; Laura E Strong; Ronald T Raines
Journal:  Cancer Biol Ther       Date:  2011-08-01       Impact factor: 4.742

2.  Tuning the pK(a) of fluorescein to optimize binding assays.

Authors:  Luke D Lavis; Thomas J Rutkoski; Ronald T Raines
Journal:  Anal Chem       Date:  2007-08-03       Impact factor: 6.986

Review 3.  Ribonuclease inhibitor: structure and function.

Authors:  Kimberly A Dickson; Marcia C Haigis; Ronald T Raines
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

4.  Multilayered films fabricated from an oligoarginine-conjugated protein promote efficient surface-mediated protein transduction.

Authors:  Christopher M Jewell; Stephen M Fuchs; Ryan M Flessner; Ronald T Raines; David M Lynn
Journal:  Biomacromolecules       Date:  2007-02-02       Impact factor: 6.988

5.  Cytotoxic ribonucleases: the dichotomy of Coulombic forces.

Authors:  R Jeremy Johnson; Tzu-Yuan Chao; Luke D Lavis; Ronald T Raines
Journal:  Biochemistry       Date:  2007-08-18       Impact factor: 3.162

6.  Collagen Membranes with Ribonuclease Inhibitors for Long-Term Stability of Electrochemical Aptamer-Based Sensors Employing RNA.

Authors:  Mirelis Santos-Cancel; Ryan J White
Journal:  Anal Chem       Date:  2017-05-03       Impact factor: 6.986

7.  Rational design and evaluation of mammalian ribonuclease cytotoxins.

Authors:  Jo E Lomax; Chelcie H Eller; Ronald T Raines
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

8.  Human ribonuclease with a pendant poly(ethylene glycol) inhibits tumor growth in mice.

Authors:  Thomas J Rutkoski; John A Kink; Laura E Strong; Ronald T Raines
Journal:  Transl Oncol       Date:  2013-08-01       Impact factor: 4.243

9.  Intraspecies regulation of ribonucleolytic activity.

Authors:  R Jeremy Johnson; Luke D Lavis; Ronald T Raines
Journal:  Biochemistry       Date:  2007-10-23       Impact factor: 3.162

Review 10.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.